Translate this page RSS Share this page Print this page


Managed Care Contracting Risks: An Antitrust, Government Pricing, and Fraud and Abuse Analysis

06 Apr 2017, 12:00 PM - 1:00 PM (Eastern Time)                            

Managed care contracting legal risks have increased as a result of increasing drug prices, new efforts to develop more creative “value” arrangements, and increased focus on the pharmaceutical industry by the FTC. The legal risks often are not limited to one area of law (for example, just the anti-kickback statute). 

This Webinar takes a inter-disciplinary approach to evaluating the legal risks associated with managed care contracting by pharmaceutical companies and provides practical advice regarding:

  • Antitrust Laws
  • Government Pricing Laws
  • Fraud and Abuse Laws

You can register to attend this webinar by clicking the Register link at the bottom of this page.

General information on our practice is available in our electronic publications Serving the Healthcare Industry, Around the Corner and Serving the Life Sciences Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to and specifying the list you wish to join.

You can also follow us on Twitter or Facebook.


If you have questions concerning this Roundtable Webinar, e-mail


Washington, D.C.